Drugplain

Levetiracetam Extended-Release 750 mg/1

levetiracetam · TABLET, FILM COATED, EXTENDED RELEASE · ScieGen Pharmaceuticals, Inc

No Recall History
Plain English

Levetiracetam Extended-Release is a tablet, film coated, extended release containing levetiracetam at 750 mg/1, taken oral. Manufactured by ScieGen Pharmaceuticals, Inc.

Key Facts

Brand Name
Levetiracetam Extended-Release
Generic Name
levetiracetam
NDC Code (Product)
50228-190
Manufacturer
ScieGen Pharmaceuticals, Inc
Strength
750 mg/1
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA205130
Marketing Start
11/27/2020

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective8,853 reports
seizure8,682 reports
off label use6,282 reports
maternal exposure during pregnancy3,016 reports
epilepsy2,712 reports
foetal exposure during pregnancy2,474 reports
drug interaction2,445 reports
fatigue2,404 reports
condition aggravated2,222 reports
status epilepticus2,029 reports

Frequently Asked Questions

What is Levetiracetam Extended-Release used for?

Levetiracetam Extended-Release contains levetiracetam. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.

Is Levetiracetam Extended-Release a controlled substance?

Levetiracetam Extended-Release is not classified as a controlled substance by the DEA.

What is the generic name for Levetiracetam Extended-Release?

The generic name for Levetiracetam Extended-Release is levetiracetam. There are 12 other brand versions of levetiracetam.

What is the NDC code for Levetiracetam Extended-Release 750 mg/1?

The NDC (National Drug Code) for Levetiracetam Extended-Release 750 mg/1 is 50228-190, listed by ScieGen Pharmaceuticals, Inc.

Product NDC

50228-190

Package NDC

50228-190-05

Other Levetiracetam Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)